Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Nowak

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2011
Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT databaseJohn Caddell Dickson, Livia Tossici-Bolt, Terez Sera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2011
Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal databaseLivia Tossici-Bolt, John C Dickson, Terez Sera, et al.
Clinical Lung Cancer|December 17, 2019
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy: A Randomized Controlled Trial (SUPER)Kristin Skougaard, Olga Østrup, Kasper Guldbrandsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2025
Reliability of [<sup>18</sup>F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centersKasper Foged Guldbrandsen, Markus Nowak Lonsdale, Hanne Marie Nellemann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2025
Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled TrialKasper Foged Guldbrandsen, Martin Bloch, Kristin Skougaard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2026
Corrigendum to 'Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial' [Journal of Thoracic Oncology Volume 20 Issue 8 (2025) 1086-1097]Kasper Foged Guldbrandsen, Martin Bloch, Kristin Skougaard, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2025
ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approachLærke Rosenlund, Kasper Guldbrandsen, Lise Barlebo Ahlborn, et al.
Clinical Lung Cancer|December 12, 2025
Diagnostic Accuracy of [<sup>18</sup>F]FDG PET/CT versus CT for NSCLC Surveillance: Secondary Analysis of a Randomized Clinical TrialKasper Foged Guldbrandsen, Martin Bloch, Kristin Skougaard, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2011
Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT databaseJohn Caddell Dickson, Livia Tossici-Bolt, Terez Sera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2011
Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal databaseLivia Tossici-Bolt, John C Dickson, Terez Sera, et al.
Clinical Lung Cancer|December 17, 2019
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy: A Randomized Controlled Trial (SUPER)Kristin Skougaard, Olga Østrup, Kasper Guldbrandsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2025
Reliability of [<sup>18</sup>F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centersKasper Foged Guldbrandsen, Markus Nowak Lonsdale, Hanne Marie Nellemann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2025
Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled TrialKasper Foged Guldbrandsen, Martin Bloch, Kristin Skougaard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2026
Corrigendum to 'Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial' [Journal of Thoracic Oncology Volume 20 Issue 8 (2025) 1086-1097]Kasper Foged Guldbrandsen, Martin Bloch, Kristin Skougaard, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2025
ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approachLærke Rosenlund, Kasper Guldbrandsen, Lise Barlebo Ahlborn, et al.
Clinical Lung Cancer|December 12, 2025
Diagnostic Accuracy of [<sup>18</sup>F]FDG PET/CT versus CT for NSCLC Surveillance: Secondary Analysis of a Randomized Clinical TrialKasper Foged Guldbrandsen, Martin Bloch, Kristin Skougaard, et al.
Pageof 4